It plays a critical role in the normal development of cardiovascular systems and participates in the pathogenesis of cardiac hypertrophy through activation of JAK/STAT1/3, Ras/ERK1/2, and PI3K/AKT signaling pathways [39–41]. This evidence concerns the gene MAPK3 and cardiac hypertrophy.